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Dopamine Innervation in the Thalamus:
Monkey versus Rat
Miguel A´ngel Garcı´a-Cabezas, Patricia Martı´nez-Sa´nchez, Miguel
A´ngel Sa´nchez-Gonza´lez, Miguel Garzo´n and Carmen Cavada
Departamento de Anatomı´a, Histologı´a y Neurociencia,
Facultad de Medicina, Universidad Auto´noma de Madrid, 28029
Madrid, Spain
We recently identified the thalamic dopaminergic system in the
human and macaque monkey brains, and, based on earlier reports
on the paucity of dopamine in the rat thalamus, hypothesized that
this dopaminergic system was particularly developed in primates.
Here we test this hypothesis using immunohistochemistry against
the dopamine transporter (DAT) in adult macaque and rat brains.
The extent and density of DAT-immunoreactive (-ir) axons were
remarkably greater in the macaque dorsal thalamus, where the
mediodorsal association nucleus and the ventral motor nuclei held
the densest immunolabeling. In contrast, sparse DAT immunolabel-
ing was present in the rat dorsal thalamus; it was mainly located in
the mediodorsal, paraventricular, ventral medial, and ventral lateral
nuclei. The reticular nucleus, zona incerta, and lateral habenular
nucleus held numerous DAT-ir axons in both species. Ultrastructural
analysis in the macaque mediodorsal nucleus revealed that thalamic
interneurons are a main postsynaptic target of DAT-ir axons; this
suggests that the marked expansion of the dopamine innervation in
the primate in comparison to the rodent thalamus may be related to
the presence of a sizable interneuron population in primates. We
remark that it is important to be aware of brain species differences
when using animal models of human brain disease.
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Introduction
Dopamine is an important neurotransmitter in mammalian brain
function, most notably in motor control, motivation and
cognition. Dopamine dysfunction is key to human neurological
and psychiatric disorders, including Parkinson’s disease, schizo-
phrenia and drug addiction (Di Chiara 2002). The dopaminergic
systems thought to have roles in these disorders, that is, the
mesostriatal, mesolimbic, and mesocortical, are the focus of
considerable research attention. However,what is a conspicuous
thalamic dopaminergic system was only identified recently by
our group in monkey and human brains (Sa´nchez-Gonza´lez et al.
2005; Garcı´a-Cabezas et al. 2007). We assumed that perhaps the
reported paucity of dopaminergic axons in the rat thalamus
(Groenewegen 1988; Papadopoulos and Parnavelas 1990) may
have hindered earlier recognition of the abundant dopamine
innervation in the primate thalamus even though considerable
scattered evidence supported its presence (reviewed in Garcı´a-
Cabezas et al. 2007). It should be pointed out that the published
rat studies were based on immunohistochemistry against
dopamine, and this technique is technically difficult and of
limited sensitivity (Groenewegen 1988; Papadopoulos and
Parnavelas 1990; Garcı´a-Cabezas et al. 2007). In our laboratory,
dopamine immunohistochemistry in monkeys has provided
useful information mainly to assess the very dense innervation of
the thalamic midline nuclei (Sa´nchez-Gonza´lez et al. 2005;
Garcı´a-Cabezas et al. 2007), where most of the axons come from
dopaminergic neurons that do not express the dopamine
transporter (DAT) (Sa´nchez-Gonza´lez et al. 2005). However,
most of the data we gathered on the distribution of dopaminer-
gic axons in the primate thalamus relied on immunohistochem-
istry against DAT, which is very sensitive and a specificmarker of
the dopaminergic phenotype (Ciliax et al. 1999).
Considering the above evidence, we reasoned that the
dopamine innervation of the rat thalamus warranted a re-
examination using the sensitive DAT-immunolabeling technique
available nowadays. Also, another question is whether rodents
actually are a useful study model to investigate the role of the
thalamic dopaminergic system in conditions linked to dopamine
dysfunction.We therefore designed the present study to compare
the thalamic dopamine innervation in the macaque monkey and
rat brains. We used DAT immunohistochemistry in parasagittal
sections of both species and in coronal rat brain sections. Thuswe
were able to collect information on the distribution of DAT-
immunoreactive (-ir) axons in the rat thalamus, and complement
the information on the distribution of the dopamine innervation
in themacaque thalamus thatwe hadmappedon coronal sections
in previous studies (Garcı´a-Cabezas et al. 2007). Moreover, by
examining the ultrastructure of the DAT-ir axons in the macaque
mediodorsal thalamic nucleus (MD) it has been possible to
identify their postsynaptic targets.
Materials and Methods
Subjects and Tissue Preparation
The parasagittal maps of the thalamus in Figures 1 and 2 are derived
from the right hemispheres of an adult male Macaca fascicularis
monkey weighing 3.5 kg, and of an adult male Sprague--Dawley rat
weighing 305 g. The left hemisphere from the same rat, sectioned in
the parasagittal plane, and the brains of 2 additional male rats, weighing
300 and 350 g, and sectioned in the coronal plane, were also processed
and analyzed under the light microscope. One of these rat brains had
received injections of fluorescent axonal tracers in the left striatum and
thalamus prior to perfusion. The thalamic injections were very small and
did not impair the DAT immunoreaction, and so the intact hemithalamus
and most of the injected hemithalamus were available for study.
The ultrastructural analysis was performed on tissue from 2 adult
male Macaca mulatta monkeys weighing 7.9 and 4.5 kg. The left
hemisphere from one of these monkeys was a gift from Dr Uwe Ilg and
Dr Peter Thier, University of Tu¨bingen, Germany. The right hemisphere
from this animal had been used for electrophysiological recordings and
subsequent injection of the various axonal tracers in different cortical
areas: diamidino yellow in the middle temporal visual area, fast blue in
the medial superior temporal visual area, cholera toxin b-subunit
conjugated to colloidal gold in the frontal eye field, biotinylated dextran
amine in the supplementary eye field and horseradish peroxidase
conjugated to wheat germ agglutinin in the lateral intraparietal area. It
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is very unlikely that these tracers interfered with the DAT immunolab-
eling carried out in the thalamus of the opposite hemisphere because
1) crossed thalamo-cortical projections from the MD to the macaque
prefrontal and temporo-parietal cortices are not thought to exist
(Preuss and Goldman-Rakic 1987; Boussaoud et al. 1992; Cavada and
Goldman-Rakic 1993); 2) the very limited crossed corticothalamic
projection from the prefrontal cortex to MD targets the dorsomedial
angle of the nucleus (Preuss and Goldman-Rakic 1987); neither the
prefrontal cortex proper, nor its contralalateral MD target zone were
injected or sampled in the animal used in the present study. In fact, the
features of DAT immunolabeling observed in the MD from the naı¨ve
animal and from the one that had received axonal tracer injections in
the opposite hemisphere were similar (see below), indicating that in
actuality the tracers did not affect the findings in the present study.
Animal handling followed Spanish and European guidelines (Boletı´n
Oficial del Estado of 18 March 1988, and 86/609/EEC and 2003/65/EC
European Council Directives) and was approved by the Committee for
Research Ethics of the Universidad Auto´noma de Madrid.
Following deep anesthesia, the animals were perfused through the
heart and ascending aorta with saline, a fixation solution and a series of
buffered sucrose solutions for cryoprotection as described earlier
(Sa´nchez-Gonza´lez et al. 2005; Garcı´a-Cabezas et al. 2007). The fixation
solution contained 4% paraformaldedyde in all animals except one of
the monkeys, which was fixed with a mixture of 4% paraformaldehyde
and 0.2% glutaraldehyde for ultrastructural analysis.
The monkey and rat hemispheres to be used for light microscopy
were frozen-sectioned at 40 lm in the parasagittal or coronal planes.
The hemispheres to be used for electron microscopy were blocked in
Figure 1. Distribution of DAT-ir axons (red) in parasagittal sections of the macaque monkey thalamus. DAT-ir axons are presented over micrographs of adjacent sections stained
for AChE activity, which were the main reference for identifying the thalamic nuclei. The AChE micrographs were rendered partially transparent to attenuate contrast and facilitate
visualization of the DAT-ir axons. The lateral distance from the midline is given for each section; anterior is to the right and posterior to the left. Note the marked differences in
DAT-ir axonal density between the various nuclei, with the MD nucleus (the lateral sector in the figure —MDl—) and the ventral thalamic nuclei holding the densest
immunolabeling. The plain grey zones in A and B correspond to tissue regions damaged in the immunoreacted sections. The calibration bar applies to (A) and (B). AD, anterodorsal
nucleus; AM, anteromedial nucleus; AV, anteroventral nucleus; Cd, caudate nucleus; Ci, internal capsule; CL, central lateral nucleus; CM-Pf, centromedian-parafascicular complex;
Csl, central nucleus-superior lateral part; Itp, inferior thalamic peduncule; LD, lateral dorsal nucleus; Li, limitans nucleus; Lme, external medullary lamina; MDl, mediodorsal
nucleus-lateral sector; MDv, mediodorsal nucleus-ventral sector; MDp, mediodorsal nucleus-posterior sector; Pcn, paracentral nucleus; Pf, parafascicular nucleus; Pt, parataenial
nucleus; Pul M, medial pulvinar nucleus; Pul O, oral pulvinar nucleus; R, reticular nucleus; VAmc, ventral anterior nucleus-magnocellular part; VApc, ventral anterior nucleus-
parvocellular part; VAvm, ventral anterior nucleus-ventromedial part; VLc, ventral lateral nucleus-caudal part; VLm, ventral lateral nucleus-medial part; VLo, ventral lateral nucleus-
oral part; VPI, ventral posterior inferior nucleus; VPLo, ventral posterior lateral nucleus-oral part; VPM, ventral posterior medial nucleus; VPMpc, ventral posterior medial nucleus-
parvocellular part; X, ventral lateral nucleus-area X; ZI, zona incerta.
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the coronal plane; slabs from the thalamus were dissected and then
sectioned in a vibratome at 40 lm. In all cases, series of adjacent
sections were collected. One series was always processed for
acetylcholinesterase (AChE) activity, which is particularly useful to
identify the thalamic nuclei (Paxinos and Watson 1986; Cavada et al.
1995). An additional series from the monkey and rat hemispheres to be
used for mapping was stained with cresyl violet for cytoarchitectural
reference. The remaining series were stored at –20 C in an ethylene-
glycol buffered solution or used for DAT immunostaining.
Immunohistochemistry
DAT immunostaining was performed on free-floating sections as
described earlier in detail (Sa´nchez-Gonza´lez et al. 2005; Garcı´a-
Cabezas et al. 2007). Thus, only a brief account is given here.
The monkey and rat tissue to be examined under the light
microscope was subject to microwave antigen retrieval prior to
immunostaining in order to optimize the immunolabeling. The monkey
and rat parasagittal sections used for mapping were immunoreacted
together to maximize the comparability of the data; the remaining rat
tissue was immunoreacted in independent experiments using the same
protocol. The coronal sections used for electron microscopy were
incubated in a cryoprotectant solution (25% sucrose and 3% glycerol in
0.05 M phosphate buffer) for 50 min and then rapidly freeze-thawed by
immersion in liquid nitrogen to enhance the penetration of immunore-
agents. Thereafter, these sections underwent the same immunohisto-
chemical procedure as the tissue for light microscopy, save for the
complete omission of Triton X-100 in the incubations. The primary
antibody was MAB369, a rat monoclonal supplied by Chemicon
International (Temecula, CA). This antibody corresponds to the DAT/
Nt antibody generated against human DAT N-terminus aminoacids 1--66
by Ciliax et al. (1995), who demonstrated its specificity using
immunoblot analysis, immunoprecipitation, preadsorption followed by
immunoblotting and immunohistochemistry, and several immunohis-
tochemical assays. MAB369 was used at a 1:1000 dilution. The
secondary antiserum was AP164B, a biotinylated rabbit anti-rat
antiserum, from the same company, used at a 1:400 dilution. The
sections were incubated in Vectastain Elite avidin/biotin complex from
Vector Labs (Burligame, CA) prior to peroxidase development. The
sensitive glucose oxidase--diaminobenzidine--nickel method (Shu et al.
1988) was used to develop the rat and monkey sections to be examined
under the light microscope. A standard diaminobenzidine protocol
(0.05% diaminobenzidine and 0.003% H2O2) was used to develop the
monkey sections to be processed for ultrastructural analysis.
In all immunostaining sessions, negative control sections containing
structures rich in DAT, like the caudate nucleus, were run in parallel
with the experimental sections. In the negative controls, the primary
antibody was omitted from the protocol. No immunolabeling was
observed in these negative control sections. Positive control tissue
included the ventral tegmental area, substantia nigra, and caudate
nucleus, which were present in many of the experimental sections (e.g.
Figs 1B, 2D). As expected, the DAT-rich centers were densely stained in
the experimental sections from both monkeys and rats.
Electron Microscope Methods
Three vibratome sections from the thalamus of 2 monkeys were DAT
immunoreacted, postfixed in 1% osmium tetroxide for 60 min, and
dehydrated through a graded series of ethanol and propylene oxide.
These sections were incubated overnight in a 1:1 mixture of propylene
oxide and Epon resin (EM bed-812; Electron Microscopy Sciences, Fort
Washington, PA), transferred to Epon 100% for 2--3 h, flat-embedded
between 2 sheets of Aclar plastic film, and cured in an oven at 58 C for
72 h. Small portions (approx. 3--4 mm2) of theMD nucleus were selected
using a dissecting magnifying microscope, cut from the sections and
glued onto resin blocks. Ultrathin tissue sections (40--60 nm) were cut
Figure 2. Distribution of DAT-ir axons (red) in parasagittal sections of the rat thalamus. DAT-ir axons are presented over micrographs of nearby sections stained for AChE activity that
reveal the various thalamic nuclei; these micrographs were rendered partially transparent to attenuate contrast and facilitate visualization of the DAT-ir axons. The lateral distance from the
midline is given for each section; anterior is to the right, and posterior to the left in all sections. Note the paucity of immunolabeling in the dorsal thalamic nuclei and compare with the
noticeable and extensive labeling in the dorsal thalamic nuclei of the monkey thalamus presented in Figure 1. In the rat, the structures most densely labeled are outside the dorsal
thalamus: thalamic reticular nucleus (R), zona incerta (ZI), and lateral habenular nucleus (Hl). The calibration bar applies to (A)-(D). AD, anterodorsal nucleus; AM, anteromedial nucleus;
AV, anteroventral nucleus; Ca, anterior commissure; Cd, caudate nucleus; Ci, internal capsule; CL, central lateral nucleus; F, fornix; Hm, medial habenular nucleus; LD, lateral dorsal
nucleus; LP, lateral posterior nucleus; MD, mediodorsal nucleus; Pf, parafascicular nucleus; Po, posterior nucleus; Pt, parataenial nucleus; Pv, paraventricular nucleus; Thi, habenulo-
interpeduncular tract; VL, ventral lateral nucleus; VM, ventral medial nucleus; VPL, ventral posterior lateral nucleus; VPM, ventral posterior medial nucleus.
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from the outer surface of the blocks and collected on coppermesh grids.
The sections were counterstained for 4 min with 5% uranyl acetate in
methanol followed by a solution containing 0.022 mg of lead citrate in
0.5 mL of NaOH 1 N and 4.5 mL of distilled water.
Data Analysis
The monkey and rat sections processed for light microscopy were
examined with a Zeiss Axioskop microscope (Oberkochen, Germany).
The DAT-ir axons present in the parasagittal monkey and rat sections
were drawn using a Neurolucida set-up (MicroBrightField, Colchester,
VT) attached to another Zeiss Axioskop microscope as described
earlier (Garcı´a-Cabezas et al. 2007). The borders of the diencephalon
and blood vessels were drawn over the immunostained sections and
were then superimposed onto the AChE sections so that the borders of
the thalamic nuclei could be traced. As well, the cresyl violet sections
were routinely used to identify the thalamic nuclei; they were
particularly useful for distinguishing the various monkey ventral nuclei.
In addition to our earlier studies on AChE activity in the monkey
thalamus (Cavada et al. 1995), reference atlases were used to identify
the monkey and rat thalamic nuclei (Olszewski 1952; Paxinos and
Watson 1986; Ilinsky and Kultas-Ilinsky 2002). The nomenclature used
for the thalamic nuclei is based on Olszewski (1952); nuclei specific to
the rat thalamus are named following Paxinos and Watson (1986). The
micrographs of Figures 1--4 were made with a digital camera (AxioCam
HRc, Zeiss, Germany) mounted onto a Zeiss Axiophot microscope
(Oberkochen, Germany).
The ultrastructural analysis was conducted with a Jeol JEM 1010
electron microscope. Electron micrographs at 20 0003 and 40 0003
magnifications were taken with a digital camera (BioScan—GATAN,
Pleasanton, CA) and saved in TIFF format. The micrographs were from
ultrathin sections collected near the surface of the tissue at the
interface with the Epon embedding resin. The MD regions examined
included the lateral (MDl) and medial sectors of the nucleus. The
classification of cellular profiles was based on the descriptions of Peters
et al. (1991). Dendrites were identified by the presence of postsynaptic
densities and/or an abundance of endoplasmic reticulum and micro-
tubules. Axons were recognized by their small caliber, smaller than any
dendritic profile, and by their lack of ribosomes. When sectioned
transversely, axons had smooth contours and were often grouped in
bundles. Axons cut longitudinally usually displayed varicosities with
vesicles. Synapses were defined as either symmetric or asymmetric
depending on the respective presence of thin or thick postsynaptic
specializations. Nonsynaptic contacts or appositions were defined as
close membranous associations that lacked recognizable specializa-
tions. A neuronal profile was considered to be selectively labeled with
immunoperoxidase when the precipitate made it appear more electron
dense than morphologically similar profiles observed within the same
section. All DAT-ir profiles were identified based on the morphological
characteristics of the tissue and the presence of DAT immunolabeling.
The diameter, perimeter and surface area of the DAT-ir profiles were
measured using the public domain NIH ImageJ 1.33 program (de-
veloped at the US National Institutes of Health and available on the
Internet at http://rsb.info.nih.gov/nih-image/).
Canvas X software (ACD Systems, Miami, FL) was used to build and
label all the Figures. Retouching of the micrographs included gray scale
rendering (Figs 1--4), transparency adjustments (Figs 1 and 2), and small
changes of brightness and contrast.
Results
Distribution of DAT-ir Axons in the Monkey and Rat
Thalamus
Figure 1 shows the distribution of macaque DAT-ir axons
superimposed onto micrographs of the adjacent AChE-stained
sections. Note the uneven distribution of the labeling
throughout the various nuclei, as well as within individual
nuclei like the MD or the oral part of the ventral lateral (VL)
nucleus. The densest immunolabeling was in the association
MD nucleus (MDl sector in Fig. 1, see also Fig. 3A) and in
several ventral motor nuclei, including the magnocellular and
parvocellular parts of the ventral anterior (VA) nucleus, the
oral, caudal, and medial parts of the VL nucleus, area X, and the
oral part of the ventral posterior lateral nucleus (VPLo). Lower
densities of DAT-ir axons were present in the anterior nuclear
group as a whole, in particular in the anteromedial (the most
densely innervated within the anterior group) and anteroven-
tral (AV) nuclei, in the intralaminar central lateral (CL) nucleus
and centromedian--parafascicular (CM--Pf) complex (where the
-ir axons are concentrated in the parafascicular nucleus -Pf-),
and in the medial pulvinar nucleus. The anterodorsal nucleus,
lateral dorsal nucleus, the anterior intralaminar paracentral
nucleus, the midline nuclei paratenial (Pt) and central-superior,
lateral part, and nucleus limitans showed very low immunos-
taining. These observations are broadly in keeping with our
earlier descriptions based on coronal sections from the
thalamus of Macaca nemestrina (Sa´nchez-Gonza´lez et al.
2005; Garcı´a-Cabezas et al. 2007). In addition, conspicuous
immunolabeling was present in the region of the ventral
posterior medial nucleus (VPM) lying ventral to the CM--Pf
complex, and in the parvocellular VPM (VPMpc) (Fig. 1B). The
marked immunolabeling in the ventral VPM region was
unexpected; in previous studies, the VPM nucleus showed
weak immunostaining (Sa´nchez-Gonza´lez et al. 2005; Garcı´a-
Cabezas et al. 2007). The ventral VPM region mapped in the
present study was not included in the previous monkey maps.
It holds the trigeminal representation of ipsilateral inner mouth
mucous surfaces: fauces, palate, mouth floor, and tongue
(Rausell and Jones 1991). It appears that this ventral VPM
region and the adjacent gustatory VPMpc are more innervated
by DAT-expressing axons than the more lateral parts of VPM
that hold the representation of facial and scalp skin. Neverthe-
less, it should be noted that VPMpc and the ventral VPM
contain many thick DAT-ir axons, sometimes grouped in
bundles, that appear to cross the nucleus in a ventro-dorsal
direction (Fig. 4). Thus, the density of DAT-ir axons mapped in
these nuclei in Figure 1B is somewhat misleading as it reflects
the presence of many axons of passage in addition to thin
varicose axons possibly innervating the neuronal populations of
VPMpc and the ventral VPM region.
Outside the dorsal thalamus, significant DAT-ir labeling was
present in the reticular nucleus (R) (Fig. 3C) and in the zona
incerta (ZI).
Figure 2 shows the distribution ofDAT-ir axons throughout the
rat thalamus. The sections selected for illustration were those
with the most extensive DAT immunolabeling. Comparison with
Figure 1 shows that the rat thalamus is quite poor in DAT-ir axons
as compared with the monkey thalamus. The nuclei holding the
densest immunolabeling in rats were not in the dorsal thalamus
proper; rather, the epithalamic lateral habenular nucleus (Hl)
held the densest immunolabeling (Fig. 2A), followed by the
ventral thalamic R nucleus (Figs 2B--D and 3D) and the ZI. Within
the dorsal thalamus the following nuclei showed low densities of
DAT-ir axons: the midline paraventricular (Pv), the MD (Fig. 3B),
and the ventral nuclei ventral medial (VM) and VL (Fig. 2A--C).
ScatteredDAT-ir axonswere present in Pt, AV, CL, and Pf.Wepaid
particular attention to the lateral geniculate nucleus (GL) because
earlier reports demonstrated the presence of dopamine-ir axons
there (Papadopoulos and Parnavelas 1990). However, we were
unable to detect DAT-ir axons in any of the 6 rat GL nuclei
examined.
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We wish to note that the DAT immunoreaction in the rat
hemisphere selected for mapping was optimal, as confirmed, in
particular, in the mesencephalon and cerebral cortex. In the
frontal and cingulate cortices from the same sections repre-
sented in Figure 2, DAT-ir axons were intensely stained; in fact
they were far more easily detected than in the thalamus where
their thin diameters made them somewhat difficult to detect.
The findings from the 2 rat brains sectioned in the coronal
plane agreed with those illustrated in Figure 2. All considered,
we conclude that the reduced DAT immunolabeling present in
the rat thalamus as compared with the monkey thalamus is
a genuine finding and not a technical artifact.
Ultrastructure of Macaque DAT-ir Axons
All DAT-ir axons were unmyelinated, varicose, and very thin
(Fig. 5); they were all in the extraglomerular neuropil of MD,
and, when cut longitudinally, they had a tortuous and irregular
course. DAT immunoreaction product showed a discrete
localization to restricted segments of the axons: it was present
either in intervaricose spaces or in varicose enlargements, but
was not detected in terminal enlargements (boutons termi-
naux). No differences were observed between the 2 monkeys
examined (n = 227 and 67 axons, respectively); thus, their data
were pooled.
The majority of the DAT-ir axons (82%) showed the
immunoperoxidase reaction product apposed to the inner
surface of the plasmalemma, as well as in the cytoplasm,
vesicles and other organelles (Fig. 5A,B). In two-thirds of these
axons, the DAT-ir was prominently associated to the plasma
membrane, that is, apposed the inner surface of the plasma-
lemma along portions of variable length, and was intensely
electron dense. We name this pattern of labeling DAT-Type I
(Fig. 5A). The remaining one-third of the axons with
immunoperoxidase apposed to the plasmalemma showed
a preferential localization of the DAT immunoprecipitate
within the cytoplasm and axonal organelles. We name this
pattern of labeling DAT-Type II (Fig. 5B). Overall, the
immunoprecipitate was paler in axons with DAT-Type II than
in those with DAT-Type I immunolabeling. DAT-Type I and
DAT-Type II labeling patterns were present in 62% and 20%,
respectively, of the studied axon population. In the remaining
Figure 3. Micrographs of representative thalamic nuclei holding DAT-ir axons (black) in the monkey and rat thalamus. The rat fields shown are those with the densest
immunolabeling in the rat thalamus; they correspond to the MD labeling mapped in Figure 2A and the reticular nucleus (R) labeling shown in Figure 2D. In the monkey thalamus
notably more extensive labeling was present in MD and R, as represented also in Figure 1. Ci, internal capsule. The calibration bar applies to (A)--(D).
Figure 4. Photomicrograph of DAT-ir axons (black) in the monkey VPM region lying
ventral to the CM--Pf complex, and in the VPMpc. Note the presence of many thick
DAT-ir axons in both nuclei that are either isolated (black arrowheads) or grouped in
bundles (black arrows). Some of the thick DAT-ir axons show a ringlet-like shape
(black arrowhead outlined in white). The thick DAT-ir axons, possibly representing
passing axons, are mixed with the typical thin varicose axons prevalent in most other
thalamic nuclei.
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18% of the axons, the immunolabeling was located within the
cytoplasm and mostly associated to microtubules, whereas the
plasmalemma was devoid of immunoprecipitate. We name this
pattern of labeling DAT-Type III (Fig. 5C).
The mean cross-section diameter of axons with DAT-Type I
immunolabeling was 0.13 lm (SD = 0.04), their mean perimeter
was 0.81 lm (SD = 0.29), and mean surface area was 0.04 lm2
(SD = 0.02). The mean diameter of axons with DAT-Type II
immunolabeling was 0.16 lm (SD = 0.07), their mean perimeter
was 0.96 lm (SD = 0.50), and mean surface area was 0.06 lm2
(SD = 0.06). The mean diameter of axons with DAT-Type III
immunolabeling was 0.17 lm (SD = 0.06), their mean perimeter
was 0.88 lm (SD = 0.34), and mean surface area was 0.05 lm2
(SD = 0.03). Because in cross-section a mean diameter may
include measurements of both varicosities and intervaricose
segments, we also measured the diameters of varicosities and
intervaricose segments in longitudinally cut DAT-ir axons (n =
70). The mean diameter of varicosities for axons with DAT-
Type I, DAT-Type II and DAT-Type III labeling patterns was
0.16 lm (SD = 0.05), 0.16 lm (SD = 0.05), and 0.16 lm (SD =
0.02), respectively; and the mean diameter of intervaricose
segments was 0.08 lm (SD = 0.05), 0.09 lm (SD = 0.04), and
0.08 lm (SD = 0.03), respectively. This indicates that the
diameters of varicosities and intervaricose segments in axons
with DAT-Type I, DAT-Type II, and DAT-Type III labeling
patterns are similar and that the measurements made in cross-
section probably contained a larger number of varicosities for
axons with DAT-Type II and DAT-Type III patterns than for
axons with DAT-Type I labeling pattern.
Very few membrane contacts (n = 9) were observed in the
population of macaque DAT-ir axons analyzed. Most contacts
(n = 7) occurred in axons with DAT-Type I immunolabeling.
Bona fide synaptic junctions with clear membrane special-
izations were observed in 5 axons with DAT-Type I immuno-
labeling and in one axon with DAT-Type II immunolabeling; 5
of these synaptic junctions were asymmetric (4 in axons with
DAT-Type I immunolabeling, one in the axon with the DAT-
Type II immunolabeling) and one was a symmetric contact (in
an axon with DAT-Type I immunolabeling). In most cases the
immunoprecipitate appeared distant from the synaptic contact
(Fig. 5D), at a mean distance of 0.49 lm (SD = 0.38) for the
asymmetric synapses. In the one synapse identified as
symmetric the immunoprecipitate was located next to the
synaptic contact. In all synaptic contacts, the postsynaptic
profile was a dendrite with vesicles (Fig. 5D); this is
characteristic of presynaptic dendrites from thalamic inter-
neurons, including those of the macaque MD (Schwartz et al.
1991; Schwartz and Mrzljak 1993). No axo-somatic contacts
were observed. Finally, 2 axons with DAT-Type I immunolabel-
ing and one with DAT-Type II immunolabeling established
appositional contacts without membrane specializations, clas-
sified as puncta adherens. The contacted profile was, in 2
cases, a dendrite devoid of vesicles, thus presumed to be
a projection neuron dendrite, and, in the third case, by an axon
with DAT-Type I immunolabeling, it was a dendrite with
vesicles, which was thus identified as an interneuron dendrite.
Discussion
The main finding from the present study is that the dopamine
innervation of the thalamus, as evidenced by DAT immunos-
taining, is markedly denser and more widespread in the
Figure 5. Ultrastructure of DAT-ir axons in the macaque MD. (A--C) Transversely cut
inmunolabeled axons showing the 3 types of labeling we identified. (D) Longitudinally
cut immunolabeled axon with its terminal endowed with vesicles and a synaptic
profile (identified in color in the inset). White arrows in (A)--(C) point to
immunoprecipitate in the cytoplasm and axonal organelles. White arrowheads in
(A), (B), and (D) point to immunoprecipitate rimming the inner border of the plasma
membrane, a feature present in DAT-Type I and DAT-Type II immunolabeling patterns.
DAT-Type I immunolabeling is characterized by intensely electron dense immunopre-
cipitate conspicuously attached to the plasma membrane (A and D), whereas DAT-
Type II immunolabeling is characterized by the immunoprecipitate preferentially
located within the cytoplasm and its organelles (B). In the DAT-Type III
immunolabeling pattern, the immunoprecipitate is confined to the cytoplasm and
mostly associated to microtubules (C). The axon in D establishes a synaptic contact
(black arrowhead) that is located far from the DAT immunoperoxidase product (white
arrowheads). The axon terminal contains many synaptic vesicles, some of them with
dense cores (black arrows). Note the presence of vesicles in the postsynaptic
element, thus identified as a presynaptic dendrite (PrsD), typical of thalamic
interneurons. The calibration bar in (C) applies to (A)--(C).
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macaque monkey than in the rat. This finding confirms our
presumption of a thalamic dopaminergic system especially
developed in primates that was inferred from independent
reports and based on findings using different methodologies
applied to the primate (Sa´nchez-Gonza´lez et al. 2005; Garcı´a-
Cabezas et al. 2007) and the rat (Groenewegen 1988;
Papadopoulos and Parnavelas 1990). In addition, the present
ultrastructural analysis shows that, in the macaque MD nucleus,
DAT is located in very thin unmyelinated axons at a distance of
several tenths of a micron from synaptic terminals. These DAT-
expressing axons appear to target mostly thalamic interneurons.
DAT-Expressing Axons in the Macaque and Rat Thalamus.
Species Differences
The present data on the distribution of thalamic DAT-ir axons
in parasagittal sections from M. fascicularis largely confirm our
earlier descriptions based on coronal sections from Macaca
nemestrina and M. mulatta: the DAT-expressing axons are
unevenly distributed between the different nuclei and within
individual nuclei, and the thalamic nuclei receiving the densest
innervation from DAT-expressing axons are the association MD
nucleus and motor ventral nuclei, including VA, VL, and VPLo.
Two additional thalamic territories, not included in the present
monkey maps, are also densely innervated by dopamine: the
association lateral posterior (LP) nucleus, which holds a dense
innervation by DAT-expressing axons, and the midline nuclei,
which hold a dense dopamine innervation mostly from axons
either devoid of or poor in DAT (Sa´nchez-Gonza´lez et al. 2005;
Garcı´a-Cabezas et al. 2007). Other thalamic nuclei show
moderate or low dopamine innervation (Fig. 1).
The different densities of the dopamine innervation in the
primate thalamic nuclei are expressed in Figure 6 by different
intensities of red. In light of the dopamine innervation in the
thalamic nuclei and the tight connections between thalamus
and cortex, it follows that the cortical regions most influenced
by thalamic dopamine are the prefrontal and motor cortices,
which themselves receive a strong direct dopamine innervation
(Williams and Goldman-Rakic 1993; Lewis et al. 2001), and
dorsal portions of the posterior parietal cortex (Fig. 6; see
review of primate thalamo-cortical connections of the nuclei
with high or moderate dopamine innervation in Table 1 of
Garcı´a-Cabezas et al. 2007). The cingulate cortex and large
territories of parieto-occipito-temporal association cortex
would be moderately influenced by thalamic dopamine while
the primary sensory areas would be the least influenced
(Fig. 6). The present data provide, however, an exception to
this general scheme: the primary gustatory cortex and the
nearby primary somatosensory cortex where the inner mouth
mucosa is represented (located in the frontal operculum and
adjacent anterior parietal cortex—Krubitzer et al. 1995; Hirata
et al. 2005; Miyamoto et al. 2006; Smits et al. 2007), receive
connections from thalamic nuclei that appear moderately
innervated by DAT-expressing axons, specifically, from VPMpc
and the ventral part of VPM (Figs 1 and 4).
In marked contrast with the prominent presence of DAT-
expressing axons in the monkey thalamus, the rat thalamus
holds only limited clusters of axons and scattered axons that
express DAT (Fig. 2). Our findings of DAT-positive axon
clusters in the Pv and MD nuclei, and in the Hl, are consistent
with the reported presence of dopamine-ir fibers in these
nuclei (Groenewegen 1988) and with changes described in rat
Figure 6. Influence of thalamic dopamine on primate cortical function as inferred from the density of the dopamine innervation in the thalamus (represented by three different
intensities of red) and from the organization of thalamo-cortical connections. The cortical regions receiving input from the most densely dopamine innervated thalamic nuclei are
represented in the darkest gray color to indicate the impact of thalamic dopamine on their corresponding functional domains. These regions include the prefrontal and motor
cortices and part of the posterior parietal cortex. In contrast, the cortical areas receiving input from the thalamic nuclei with the least dopamine innervation are shown in the
lightest gray shade and correspond to the primary visual (VI), auditory (AI), and somatosensory (SI) areas. A, anterior group of nuclei; CL, central lateral nucleus; CM-Pf,
centromedian-parafascicular complex; GL, lateral geniculate nucleus; GM, medial geniculate nucleus; LD, lateral dorsal nucleus; LP, lateral posterior nucleus; M, midline group of
nuclei; MD, mediodorsal nucleus; Pcn, paracentral nucleus; Pul, pulvinar nuclei; R, reticular nucleus; VA, ventral anterior nucleus; VL, ventral lateral nucleus; VPL, ventral posterior
lateral nucleus; VPM, ventral posterior medial nucleus; VPMpc, ventral posterior medial nucleus-parvocellular part.
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MD neuron membrane properties following D2 receptor
stimulation (Lavin and Grace 1998). In the present study we
also found substantial DAT immunolabeling in the rat R nucleus
and ZI, and clusters of DAT-ir axons in the VM and VL ventral
nuclei, and scattered DAT-ir axons in Pt, AV, CL, and Pf. The
presence of DAT-ir axons in the rat Pv, Hl and R concurs with
tract-tracing studies reporting projections to these nuclei from
dopaminergic neurons of the fore-and/or midbrain (Takada
et al. 1990; Li et al. 1993; Anaya-Martinez et al. 2006). However,
we did not observe DAT-ir axons in the GL, where dopamine-ir
axons have been reported (Papadopoulos and Parnavelas 1990),
and a number of studies have shown that delivery there of
dopamine or dopamine-receptor agonists has an effect on
neuronal activity (Albrecht et al. 1996; Govindaiah and Cox
2005; Munsch et al. 2005). It is possible that dopaminergic
axons in the GL nucleus, if present, are devoid of DAT or
express it below the threshold level for our methods. It should
be borne in mind that not all dopaminergic neurons express
DAT (Sa´nchez-Gonza´lez et al. 2005); that, among those
expressing it, levels are variable (Haber et al. 1995; Sa´nchez-
Gonza´lez et al. 2005); and that some dopaminergic cell groups,
specifically A8 through A11, hold a mixed population of cell
bodies that, being dopaminergic, are either DAT-positive or
DAT-negative (Table 1 in Sa´nchez-Gonza´lez et al., 2005). Tract-
tracing data in the monkey show that the thalamus receives
projections from both dopaminergic DAT-positive and DAT-
negative neurons. In the midline nuclei, for example, the
majority of the dopaminergic axons come from hypothalamic
and lateral parabrachial dopaminergic cell groups that do not
express DAT; the non-midline nuclei, which make up most of
the thalamic volume, however, receive the bulk of their
afferent dopaminergic input from DAT-expressing cell groups
(Sa´nchez-Gonza´lez et al. 2005). It is possible, then, that the rat
GL nucleus receives dopaminergic input from neurons that do
not express DAT. Examination of the origin of the dopaminer-
gic axons targeting the rat thalamic nuclei, including GL, would
help to settle if the latter receives a dopamine innervation. In
addition, it would help to clarify if the origin of the dopamine
innervation of the rat thalamus comes from such a diverse
collection of dopaminergic cell groups as in the monkey, which
includes groups that express DAT, as in the mesencephalon,
and those that are devoid of DAT expression, as in the
hypothalamus (Sa´nchez-Gonza´lez et al. 2005).
The observed expansion in extent and density of the
dopamine innervation in the primate versus the rodent dorsal
thalamus deserves comment. The general layout of dopami-
nergic cell groups is comparable in the primate and rodent
brains although dopaminergic neurons are more widely
distributed in the primate than in the rodent mesencephalon
(Kitahama et al. 1994; Verney 1999). The general distribution
of dopaminergic terminals in the striatum is also similar (Reiner
1994; Ciliax et al. 1995; Ciliax et al. 1999). In the cerebral
cortex, however, the patterns of regional and laminar
distribution of dopaminergic axons differ significantly between
primates and rodents. In rats, dopamine innervation is present
mainly in the prefrontal, anterior cingulate, insular, piriform,
entorhinal, and perirhinal cortices, with the posterior cingu-
late, motor, parietal, and temporal cortices being lightly
innervated. Dopaminergic terminals in the rat cortex are
distributed in deep layers with the exception of the anterior
cingulate and entorhinal cortices where they are present in
deep and superficial layers (Berger et al. 1991; Ciliax et al.
1995). In primates the dopamine innervation in the cerebral
cortex is expanded and differently distributed: it targets all
cortical areas, is densest in the motor cortices, and is present in
the deep and superficial layers with the molecular layer being
the most densely innervated in all areas (Berger et al. 1991;
Williams and Goldman-Rakic 1993; Ciliax et al. 1999; Lewis
et al. 2001). Thus, it appears that the major differences in
dopamine innervation between the rodent and primate brains
are in the cerebral cortex and dorsal thalamus (present report
and Garcı´a-Cabezas et al. 2007).
Moreover, there seems to be a correlation between the
relative densities of dopaminergic axons in the primate cortex
and thalamus, with cortical regions heavily innervated by
dopamine connected with densely innervated thalamic nuclei
(i.e., motor, prefrontal, and posterior parietal areas; ventral
motor, MD, and LP thalamic nuclei), and poorly innervated
cortical regions linked with dopamine poor thalamic nuclei
(e.g., primary visual cortex; GL nucleus). Thus, the wider and
denser dopamine innervation in the primate dorsal thalamus as
compared with the rodent may parallel the expansion of the
mesocortical dopaminergic system noted by Berger and Gaspar
(1994) in relation to encephalization.
Finally, it is opportune to add that the notable differences in
dopamine innervation between the dorsal thalamus of monkeys
and rats are not evident in the ventral thalamus and
epithalamus: the R, ZI, and Hl all show conspicuous innervation
by dopamine in the human, monkey and rat brains (present
data and Garcı´a-Cabezas et al. 2007).
Ultrastructure and Targets of Thalamic DAT-Expressing
Axons in the Monkey
The nearly 300 DAT-ir axons identified here in the monkey MD
were unmyelinated, varicose and very thin, less than 0.1 lm in
diameter. They were located in the extraglomerular neuropil
and, based on the characteristics of the immunoprecipitate, we
identified 3 immunolabeling patterns. In 82% of the axons the
immunoprecipitate was apposed to the inner plasmalemma
surface (this defined the DAT-Type I and DAT-Type II
immunolabeling patterns, distinguished by their intense or
pale immunoprecipitate, respectively); in the remaining 18% of
the axons the immunoprecipitate was confined to the
cytoplasm and was mostly linked to microtubules (DAT-Type
III immunolabeling). These observations expand those
reported using DAT and tyrosine hydroxylase immunohisto-
chemistry in the macaque MD (Melchitzky et al. 2006).
Melchitzky and colleagues concluded that the ultrastructure
of DAT-ir axons in the MD is more similar to that of DAT-ir
axons in the cortex than in the striatum. Indeed the mean
diameters of DAT-ir axons in the monkey prefrontal cortex are
in the range of the DAT-ir axons identified here in MD: 0.14 and
0.15 lm in prefrontal areas 46 and 9, respectively (Lewis et al.
2001); 0.08--0.09 lm and 0.16 lm for intervaricose segments
and varicosities, respectively, in MD (present data). Neverthe-
less, the notion that the mesocortical and thalamic dopaminer-
gic systems are associated because they share ultrastructural
features requires a stronger justification and testing. For
example, it remains to be determined if the dopaminergic
axons in the cortex and thalamus, or a fraction of them, share
a common nuclear origin, or may even be collaterals from the
same neurons. This hypothesis is tenable because dopaminer-
gic neurons from mesencephalic groups A8, A9, and A10
project to the motor and prefrontal cortices (Gaspar et al.
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1992; Williams and Goldman-Rakic 1998) as well as the
thalamus (Sa´nchez-Gonza´lez et al. 2005).
In the relatively large number of labeled axons examined
here we were able to identify 6 synaptic junctions, 5
asymmetric and one symmetric, and their corresponding
postsynaptic profiles. In all cases, the latter showed the
features of presynaptic dendrites on a thalamic interneuron.
Identification of synapses and postsynaptic profiles in cate-
cholaminergic axons of the monkey thalamus has been elusive.
We have identified them in only 2% of the DAT-immunolabeled
axons, mostly within the population of axons that were cut
longitudinally. Despite the low numbers, the present data
represent the largest number of synaptic contacts identified to
date in thalamic dopaminergic axons. In previous studies only 3
(Liu and Jones 1991) and 2 (Melchitzky et al. 2006) synaptic
profiles were observed, all in tyrosine hydroxylase immunola-
beled axons; and hence, they were only putatively dopaminer-
gic. Among these 5 synapses the postsynaptic element was
identified in only 3 cases: it was a dendritic shaft in 2 (Liu and
Jones 1991; Melchitzky et al. 2006) and a presynaptic dendrite
in the third case (Melchitzky et al. 2006). Apart from the
number of axons analyzed, which should be high enough to
provide a sizable number of synaptic forms, a main reason for
the paucity of data on synapses and postsynaptic targets of
catecholaminergic fibers in the monkey thalamus may lie in the
plane of section. In our material synaptic specializations
appeared at a mean distance of about 0.5 lm from the DAT
immunoprecipitate; for this reason axons cut longitudinally are
more likely to display synaptic specializations. In the monkey
MD, most DAT-ir axons follow a rostro-caudal course (Fig. 1)
and thus the coronal plane of section used so far (Melchitzky
et al. 2006; present study) renders mostly transversely cut
axons (76% of the total DAT-ir axons in our material); the
parasagittal plane of section should render more longitudinally
cut axons and would thus be more appropriate for the analysis
of dopaminergic synapses. Another technical means to refine
and increase the identification of synaptic profiles in dopami-
nergic axons would be the use of serial sections. Future
exhaustive ultrastructural analyses may uncover further details
of the morphological relationships between dopaminergic
axons and their targets in the monkey thalamus.
The subcellular location of the DAT immunoprecipitate, and
the identification in the present study of the interneurons as
the predominant postsynaptic element in the monkey MD are
worth consideration. In most axons (82%) the DAT immuno-
precipitate was apposed to the membrane, and when synapses
were identified, the immunoprecipitate was located far from
them (Fig. 5D). This suggests that in the macaque MD
synaptically released dopamine may diffuse for considerable
time and distance before being re-uptaken by DAT. This
possibility is compatible with a ‘‘volume’’ or ‘‘extrasynaptic’’
transmission mode in the thalamic dopaminergic system
comparable to that proposed for the mesostriatal and meso-
cortical systems (Pickel et al. 1996; Zoli et al. 1998; Lewis et al.
2001). The plausible existence of volume transmission would
mean that the released dopamine may spread farther than the
postsynaptic neurons, thus reaching projection neurons.
Finally, in the macaque MD the thalamic interneurons appear
to be the main postsynaptic target of dopaminergic axons. The
interneurons in the macaque MD account for 25% and 35% of
the total neuronal population in the magnocellular and
parvocellular sectors, respectively, of the nucleus (Clark et al.
1989). The proportion of thalamic interneurons in other
monkey thalamic nuclei, including anterior, ventral, lateral
and intralaminar nuclei, as well as GL, is within the same range
as in MD (Montero and Zempel 1986; Hendry 1991; Hunt et al.
1991). In contrast, the rat thalamus is virtually devoid of
interneurons, except for the lateral and medial geniculate and
the LP nucleus (Ottersen and Storm-Mathisen 1984). It is thus
tempting to hypothesize that the sizable interneuron popula-
tion and the conspicuous population of dopaminergic axons
targeting the interneurons evolved in parallel and are partic-
ularly prominent in the primate brain. Nevertheless, even if this
hypothesis proves true, the uneven density of the dopamine
innervation across the various primate thalamic nuclei remains
to be explained. It is interesting, though, that uneven densities
of dopamine innervation in the cortex and thalamus seem to
coincide, and thus densely innervated cortical regions are
connected with densely innervated thalamic territories.
Concluding Remarks
We have shown marked differences in the dopamine in-
nervation of the thalamus between monkeys and rats. These
species differences should be taken into account when
considering the use of animals as models for human diseases
coursing with dopamine dysfunction, in particular Parkinson’s
disease and schizophrenia. The presence of abundant DAT in
the primate thalamus implies that the nuclei densely innervated
by DAT-expressing axons may be important sites of action of
toxins that selectively destroy dopaminergic neurons acting
through DAT (Pifl and Caron 2002). One such toxin is 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), used to
produce experimental parkinsonism in both primates and
rodents (Pifl and Caron 2002). It is possible that in MPTP-
treated monkeys the thalamic nuclei innervated by DAT-
expressing axons are dopamine dennervated (see Pifl et al.
1990, 1991, for support of this hypothesis) and that a decrease
in thalamic dopamine contributes to the pathophysiology of
parkinsonism. Such pathogenic mechanism would hardly work
in rats because their thalamic dopaminergic system is
rudimentary.
The species differences shown here should also be
considered in studies dealing with the effects on the brain of
psychoactive drugs that act through DAT, like cocaine or the
amphetamines (Pifl and Caron 2002), because the primate
brain holds more specific sites of action for those drugs than
the rodent brain, in particular in the cerebral cortex and
thalamus.
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